Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA.
暂无分享,去创建一个
M. Kool | F. Baas | R. Evers | P. Borst | C. Paulusma | J. Calafat | H. Janssen | A. Schinkel | R. O. Oude Elferink | L. Oomen | A H Schinkel | P Borst | R Evers | M Kool | L van Deemter | R. P. Elferink | L. van Deemter | L C Oomen | R P Oude Elferink | J Calafat | F Baas | H Janssen | C C Paulusma | L. Deemter | Marcel Kool | L. V. Deemter
[1] A I Caplan,et al. Stimulatory Effects of Basic Fibroblast Growth Factor and Bone Morphogenetic Protein‐2 on Osteogenic Differentiation of Rat Bone Marrow‐Derived Mesenchymal Stem Cells , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[2] I. Martin,et al. Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. , 1997, Endocrinology.
[3] M. Kool,et al. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. , 1997, Cancer research.
[4] P. Meier,et al. Functional expression of the rat liver canalicular isoform of the multidrug resistance‐associated protein , 1997, FEBS letters.
[5] K. Ueda,et al. Anti‐cancer drugs and glutathione stimulate vanadate‐induced trapping of nucleotide in multidrug resistance‐associated protein (MRP) , 1997, FEBS letters.
[6] P. Marie,et al. Age‐related changes in bone formation, osteoblastic cell proliferation, and differentiation during postnatal osteogenesis in human calvaria , 1997, Journal of cellular biochemistry.
[7] 谷口堅. A Human Canalicular Multispecific Organic Anion Transporter(cMOAT)Gene Is Overexpressed in Cisplatin-resistant Human Cancer Cell Lines with Decreased Drug Accumulation(ヒトCanalicular Multispecific Organic Anion Transporter(cMOAT)遺伝子は薬剤蓄積の減少したシスプラチン耐性ヒトがん細胞株で過剰発現している) , 1997 .
[8] Y. Sugiyama,et al. Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR. , 1997, The American journal of physiology.
[9] R. Evers,et al. Transport of the glutathione conjugate of ethacrynic acid by the human multidrug resistance protein MRP , 1996, FEBS letters.
[10] D. Donoghue,et al. Profound ligand-independent kinase activation of fibroblast growth factor receptor 3 by the activation loop mutation responsible for a lethal skeletal dysplasia, thanatophoric dysplasia type II , 1996, Molecular and cellular biology.
[11] G. Nolan,et al. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. , 1996, Human gene therapy.
[12] J. Boudreaux,et al. The rat osteocalcin fibroblast growth factor (FGF)-responsive element: an okadaic acid-sensitive, FGF-selective transcriptional response motif. , 1996, Molecular endocrinology.
[13] P. Maher,et al. Nuclear accumulation of fibroblast growth factor receptors is regulated by multiple signals in adrenal medullary cells. , 1996, Molecular biology of the cell.
[14] A. N. Meyer,et al. Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR)2 and FGFR2/Neu chimeras. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[15] P. Maher. Nuclear Translocation of fibroblast growth factor (FGF) receptors in response to FGF-2 , 1996, The Journal of cell biology.
[16] T. Ishikawa,et al. Coordinated Induction of MRP/GS-X Pump and γ-Glutamylcysteine Synthetase by Heavy Metals in Human Leukemia Cells* , 1996, The Journal of Biological Chemistry.
[17] D. Keppler,et al. cDNA Cloning of the Hepatocyte Canalicular Isoform of the Multidrug Resistance Protein, cMrp, Reveals a Novel Conjugate Export Pump Deficient in Hyperbilirubinemic Mutant Rats* , 1996, The Journal of Biological Chemistry.
[18] S. Cole,et al. Biology of the multidrug resistance-associated protein, MRP. , 1996, European journal of cancer.
[19] D. Ornitz,et al. Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia , 1996, Nature Genetics.
[20] A. Schinkel,et al. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. , 1996, The Journal of clinical investigation.
[21] D. Keppler,et al. Absence of the canalicular isoform of the MRP gene–encoded conjugate export pump from the hepatocytes in Dubin‐Johnson syndrome , 1996, Hepatology.
[22] S. Cole,et al. ATP-dependent 17-Estradiol 17-(-D-Glucuronide) Transport by Multidrug Resistance Protein (MRP) , 1996, The Journal of Biological Chemistry.
[23] S. Cole,et al. Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles. Demonstration of glutathione-dependent vincristine transport. , 1996, The Journal of biological chemistry.
[24] B. Sarkadi,et al. Transport properties of the multidrug resistance‐associated protein (MRP) in human tumour cells , 1996, FEBS letters.
[25] P. Leder,et al. Fibroblast Growth Factor Receptor 3 Is a Negative Regulator of Bone Growth , 1996, Cell.
[26] R. Evers,et al. Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells. , 1996, The Journal of clinical investigation.
[27] P. Marie,et al. Increased bone formation and osteoblastic cell phenotype in premature cranial suture ossification (craniosynostosis) , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[28] P. Bosma,et al. Congenital Jaundice in Rats with a Mutation in a Multidrug Resistance-Associated Protein Gene , 1996, Science.
[29] D. Donoghue,et al. Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia. , 1996, The EMBO journal.
[30] D. Keppler,et al. MRP Gene-encoded Conjugate Export Pump1 , 1996 .
[31] R. Friesel,et al. Constitutive Activation of Fibroblast Growth Factor Receptor-2 by a Point Mutation Associated with Crouzon Syndrome (*) , 1995, The Journal of Biological Chemistry.
[32] P. Borst,et al. Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. , 1995, The Journal of clinical investigation.
[33] D. Keppler,et al. Expression of the MRP gene-encoded conjugate export pump in liver and its selective absence from the canalicular membrane in transport- deficient mutant hepatocytes , 1995, The Journal of cell biology.
[34] F. Baas,et al. Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[35] E. Jabs,et al. Analysis of phenotypic features and FGFR2 mutations in Apert syndrome. , 1995, American journal of human genetics.
[36] D. Meijer,et al. Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport. , 1995, Biochimica et biophysica acta.
[37] N. Feller,et al. ATP‐dependent efflux of calcein by the multidrug resistance protein (MRP): no inhibition by intracellular glutathione depletion , 1995, FEBS letters.
[38] R. Scheper,et al. Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein. , 1995, British Journal of Cancer.
[39] V. Schuster,et al. Identification and characterization of a prostaglandin transporter. , 1995, Science.
[40] J. Heath,et al. Functions of fibroblast growth factors and their receptors , 1995, Current Biology.
[41] T. Nakamura,et al. Stimulation of endosteal bone formation by systemic injections of recombinant basic fibroblast growth factor in rats. , 1995, Endocrinology.
[42] W. Reardon,et al. Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome , 1995, Nature Genetics.
[43] W. Reardon,et al. Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes , 1995, Nature Genetics.
[44] M. Ouellette,et al. New mechanisms of drug resistance in parasitic protozoa. , 1995, Annual review of microbiology.
[45] I. Pastan,et al. Genetic analysis of the multidrug transporter. , 1995, Annual review of genetics.
[46] P. Borst,et al. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[47] G. M. Wilson,et al. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. , 1994, Cancer research.
[48] D. Keppler,et al. The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. , 1994, The Journal of biological chemistry.
[49] M. Eccles,et al. Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2 , 1994, Nature Genetics.
[50] W. Reardon,et al. A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome , 1994, Nature Genetics.
[51] D. Keppler,et al. ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. , 1994, Cancer research.
[52] F. Baas,et al. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[53] P. Sonneveld,et al. Expression of the multidrug resistance-associated protein (MRP) in acute and chronic leukemias. , 1994, Leukemia.
[54] P. van Bladeren,et al. Reversible conjugation of ethacrynic acid with glutathione and human glutathione S-transferase P1-1. , 1994, Cancer research.
[55] D. Keppler,et al. Differential inhibition by cyclosporins of primary‐active ATP‐dependent transporters in the hepatocyte canalicular membrane , 1993, FEBS letters.
[56] T. Ishikawa,et al. Glutathione-associated cis-diamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance. , 1993, The Journal of biological chemistry.
[57] N. Savion,et al. Effect of basic fibroblast growth factor on the growth and differentiation of adult stromal bone marrow cells: Enhanced development of mineralized bone‐like tissue in culture , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[58] P. Marie,et al. Kinetics of in vitro mineralization by an osteogenic clonal cell line (C1) derived from mouse teratocarcinoma. , 1993, Differentiation; research in biological diversity.
[59] F. Baas,et al. Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. , 1993, Cancer research.
[60] M. Hurley,et al. Basic fibroblast growth factor inhibits type I collagen gene expression in osteoblastic MC3T3-E1 cells. , 1993, The Journal of biological chemistry.
[61] P. Jansen,et al. Glutathione-conjugate transport by human colon adenocarcinoma cells (Caco-2 cells). , 1993, The Biochemical journal.
[62] D. Johnson,et al. Structural and functional diversity in the FGF receptor multigene family. , 1993, Advances in cancer research.
[63] K. Kato,et al. In vivo stimulation of endosteal bone formation by basic fibroblast growth factor in rats. , 1993, Growth factors.
[64] I. Pastan,et al. Biochemistry of multidrug resistance mediated by the multidrug transporter. , 1993, Annual review of biochemistry.
[65] A. Duncan,et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. , 1992, Science.
[66] T. Ishikawa,et al. The ATP-dependent glutathione S-conjugate export pump. , 1992, Trends in biochemical sciences.
[67] C. Higgins,et al. ABC transporters: from microorganisms to man. , 1992, Annual review of cell biology.
[68] Z. Gatmaitan,et al. Two distinct mechanisms for bilirubin glucuronide transport by rat bile canalicular membrane vesicles. Demonstration of defective ATP-dependent transport in rats (TR-) with inherited conjugated hyperbilirubinemia. , 1992, The Journal of clinical investigation.
[69] P. Leder,et al. Ligand specificity and heparin dependence of fibroblast growth factor receptors 1 and 3. , 1992, The Journal of biological chemistry.
[70] S. Tapscott,et al. Functional antagonism between c-Jun and MyoD proteins: A direct physical association , 1992, Cell.
[71] D. Keppler,et al. Leukotrienes: biosynthesis, transport, inactivation, and analysis. , 1992, Reviews of physiology, biochemistry and pharmacology.
[72] P. Jansen,et al. ATP-dependent multispecific organic anion transport system in rat erythrocyte membrane vesicles. , 1992, The American journal of physiology.
[73] P. Marie,et al. Decreased DNA synthesis by cultured osteoblastic cells in eugonadal osteoporotic men with defective bone formation. , 1991, The Journal of clinical investigation.
[74] H. Sies,et al. ATP-dependent S-(2,4-dinitrophenyl)glutathione transport in canalicular plasma membrane vesicles from rat liver. , 1991, The Journal of biological chemistry.
[75] J. Aubin,et al. Positive and negative immunoselection for enrichment of two classes of osteoprogenitor cells , 1991, The Journal of cell biology.
[76] T. Ishikawa,et al. ATP-dependent primary active transport of cysteinyl leukotrienes across liver canalicular membrane. Role of the ATP-dependent transport system for glutathione S-conjugates. , 1990, The Journal of biological chemistry.
[77] P. van Bladeren,et al. Inhibition of rat and human glutathione S-transferase isoenzymes by ethacrynic acid and its glutathione conjugate. , 1990, Biochemical pharmacology.
[78] K. Hayashi,et al. Mechanism of glutathione S-conjugate transport in canalicular and basolateral rat liver plasma membranes. , 1990, The Journal of biological chemistry.
[79] Carol L. Williams,et al. Transepithelial transport of drugs by the multidrug transporter in cultured Madin-Darby canine kidney cell epithelia. , 1989, The Journal of biological chemistry.
[80] N. Savion,et al. Basic fibroblast growth factor enhances the capacity of bone marrow cells to form bone‐like nodules in vitro , 1989, FEBS letters.
[81] G. Wesolowski,et al. Effects of acidic and basic fibroblast growth factors on osteoblastic cells. , 1989, Connective tissue research.
[82] D. Gospodarowicz,et al. Regulation of bovine bone cell proliferation by fibroblast growth factor and transforming growth factor beta. , 1988, Endocrinology.
[83] M. Kirschner,et al. Synergistic induction of mesoderm by FGF and TGF-β and the identification of an mRNA coding for FGF in the early xenopus embryo , 1987, Cell.
[84] M. Drezner,et al. Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[85] L. Brunton,et al. Prostaglandin A1 metabolism and inhibition of cyclic AMP extrusion by avian erythrocytes. , 1985, The Journal of biological chemistry.
[86] S. Fuller,et al. Vesicular stomatitis virus infects and matures only through the basolateral surface of the polarized epithelial cell line, MDCK , 1984, Cell.
[87] D. Louvard. Apical membrane aminopeptidase appears at site of cell-cell contact in cultured kidney epithelial cells. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[88] T. Eling,et al. Conjugation of 15-keto-prostaglandins by glutathione S-transferases. , 1978, Biochimica et biophysica acta.
[89] N. Andersen. Dehydration of prostaglandins: study by spectroscopic method. , 1969, Journal of lipid research.